Intel Receives $7.9 Billion in Chips Act Funding. There Are Strings Attached.
The Commerce Department calls it a “huge step” in strengthening the U.S. chip supply chain. Earlier this year, it had ...
Business Wire11m
Intel and Biden-Harris Administration Finalize $7.86 Billion Funding Award Under US CHIPS Act
The U.S. Department of Commerce has awarded Intel Corporation up to $7.86 billion in direct funding through the U.S. CHIPS ...
Biden Cuts Intel’s Chip Award by More Than $600 Million
The Silicon Valley company will receive less money from the CHIPS Act after winning a $3 billion military contract and ...
U.S. finalizes $7.86B Chips Act award for Intel to boost local manufacturing
The Biden administration has finalized up to $7.86B in direct funding for Intel (NASDAQ:INTC) as part of the CHIPS and ...
Intel Secures $7.9 Billion US Chips Award for Advanced Factories
The Biden administration has finalized a deal to give Intel Corp. nearly $7.9 billion in federal grants, the largest direct ...
Intel and Biden Administration finalize $7.86B deal to fund domestic chip manufacturing
The U.S. Department of Commerce today confirmed it has awarded $7.865 billion to chip giant Intel under the CHIPS and Science ...
The Washington Post on MSN42m
U.S. finalizes $11 billion for Intel as time runs out on Biden’s chip plan
Intel will receive $7.86 billion to build out its core manufacturing facilities, plus an additional $3 billion that was ...
Intel finalizes $7.9 billion in federal subsidies for scaled-back expansion
The Biden administration is in the uncomfortable position of awarding subsidies to a company that's cutting jobs.
US Finalizes $7.86 Billion Chips Manufacturing Award for Intel
WASHINGTON (Reuters) - The U.S. Commerce Department said Tuesday it was finalizing a $7.86 billion government subsidy for ...
US oil producers unlikely to shift to 'drill, baby, drill' mode, says Exxon executive
U.S. oil and gas producers are unlikely to radically increase production under president-elect Donald Trump as companies ...
Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion
The deal allows the pharmaceutical company to bring in house its current partner with the aim of developing cell therapies in oncology, immunology and neurology.